Ensysce Biosciences (ENSC) Price to Earnings (2018 - 2025)
Ensysce Biosciences' (ENSC) quarterly Price to Earnings came in at 2.02 in Q3 2025, down 156.36% year-over-year from 3.59 in Q3 2024, and up 34.34% quarter-over-quarter from 3.08 in Q2 2025.
Powered by 
Analysis
Ensysce Biosciences (ENSC) Price to Earnings (2018 - 2025) Analysis & Trends
Ensysce Biosciences (ENSC) has reported Price to Earnings for 8 consecutive years, with 2.02 the latest figure, recorded in Q3 2025.
- On a quarterly basis, Price to Earnings fell 156.36% year-over-year to 2.02 in Q3 2025; TTM through Sep 2025 was 0.69, a 129.45% decrease from a year earlier, with the FY2024 full-year figure at 0.71, down 214.81% from the prior year.
- Price to Earnings was 2.02 for Q3 2025 at Ensysce Biosciences, up from 3.08 in the prior quarter.
- Over five years, Price to Earnings peaked at 3.59 in Q3 2024 and troughed at 248.62 in Q2 2021.
- A 5-year average of 20.65 and a median of 2.15 in 2023 frame the typical range for Price to Earnings.
- Across the five-year window, Price to Earnings plunged 323.1% in 2021 and soared 344.09% in 2024, its largest moves.
- Over 5 years, Price to Earnings stood at 8.74 in 2021, then jumped by 96.65% to 0.29 in 2022, then tumbled by 133.53% to 0.68 in 2023, then slumped by 132.64% to 1.59 in 2024, then declined by 26.89% to 2.02 in 2025.
- The last three Price to Earnings figures came in at 2.02 (Q3 2025), 3.08 (Q2 2025), and 2.16 (Q1 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 663.08 Bn | 642.33 Bn | 17.26 Bn |
| 2 | AbbVie | 453.04 Bn | 446.51 Bn | 12.70 Bn |
| 3 | Merck | 370.87 Bn | 363.78 Bn | 12.21 Bn |
| 4 | Novartis Ag | 305.29 Bn | 298.00 Bn | 11.24 Bn |
| 5 | Pfizer | 162.10 Bn | 150.70 Bn | 10.94 Bn |
| 6 | Sanofi | 53.95 Bn | 46.98 Bn | 10.79 Bn |
| 7 | Revolution Medicines | 45.00 Bn | 45.00 Bn | - |
| 8 | Incyte | 25.47 Bn | 20.94 Bn | 1.57 Bn |
| 9 | United Therapeutics | 20.81 Bn | 18.15 Bn | 683.80 Mn |
| 10 | Ensysce Biosciences | 1.18 Mn | -3.46 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2025 | -2.02 |
| Jun 30, 2025 | -3.08 |
| Mar 31, 2025 | -2.16 |
| Dec 31, 2024 | -1.59 |
| Sep 30, 2024 | 3.59 |
| Jun 30, 2024 | -2.10 |
| Mar 31, 2024 | -1.44 |
| Dec 31, 2023 | -0.68 |
| Sep 30, 2023 | -1.47 |
| Jun 30, 2023 | -2.15 |
| Mar 31, 2023 | -2.33 |
| Dec 31, 2022 | -0.29 |
| Sep 30, 2022 | -0.96 |
| Jun 30, 2022 | -3.86 |
| Mar 31, 2022 | -20.48 |
| Dec 31, 2021 | -8.74 |
| Sep 30, 2021 | -4.28 |
| Jun 30, 2021 | -248.62 |
| Mar 31, 2021 | -89.69 |
| Dec 31, 2020 | 361.69 |